For allergic conjunctivitis1 THE POWER TO CALM THE ITCH   THE POWER OF BEPREVE®—FIRST-LINE, YEAR-ROUND, WITH BROAD-SPECTRUM ALLERGEN COVERAGE POWER of savings: New eVoucherRx program offers eligible patients up to $50 off their BEPREVE® prescription without the need for a coupon. 1. Commercially insured patients receive up to $50 off their prescription after they pay an initial $30 out of pocket.     2. Automatic rebate at the pharmacy counter; no cards or coupons needed.     3. All commercially insured patients using a participating pharmacy are eligible. Click here for a list of participating pharmacies in your area. INDICATION BEPREVE® (bepotastine besilate ophthalmic solution) 1.5% is indicated for the treatment of itching associated with allergic conjunctivitis. IMPORTANT RISK INFORMATION BEPREVE® is contraindicated in patients with a history of hypersensitivity reactions to bepotastine or any of the other ingredients. BEPREVE® is for topical ophthalmic use only. To minimize risk of contamination, do not touch the dropper tip to any surface. Keep the bottle closed when not in use. BEPREVE® should not be used to treat contact lens–related irritation. Remove contact lenses prior to instillation of BEPREVE®. The most common adverse reaction occurring in approximately 25% of patients was a mild taste following instillation. Other adverse reactions occurring in 2%-5% of patients were eye irritation, headache, and nasopharyngitis. Please click here to view the BEPREVE® full prescribing information. Reference: 1. BEPREVE [package insert]. Irvine, CA: ISTA Pharmaceuticals, Inc; 2012.                    To request samples of BEPREVE®, please click here             ®/TM are trademarks of Bausch & Lomb Incorporated or its affiliates. All other product/brand names are trademarks of their respective owners. ©2013 Bausch & Lomb Incorporated. US/BEP/12/0028 1/13 Bausch & Lomb (Global Pharmaceutical Headquarters) | 7 Giralda Farms, Suite 1001, Madison, NJ 07940 1.800.323.0000 www.bausch.com